Anti-Semaglutide (OZEMPIC) Quantitative ELISA Assay Kit

$1,750.00

The Anti-Semaglutide (OZEMPIC) Quantitative ELISA Assay Kit is intended for the quantitative analysis of antibodies to semaglutide in human serum and plasma samples. The Anti-Semaglutide (OZEMPIC) Quantitative ELISA Assay Kit is for research use only and not to be used for diagnostic procedures.

SKU: SEM-QNS-OZE Categories: , ,

Anti-Semaglutide (OZEMPIC) Quantitative ELISA Assay Kit

The Anti-Semaglutide (OZEMPIC) Quantitative ELISA Assay Kit is For Research Use Only

Size: 12 x 8 wells
Sensitivity: 5 ng/mL
Standard Range: 0 – 150 ng/mL
Incubation Time: 2 hour 20 minutes
Sample Type: Serum, Plasma
Sample Size: 25 µL
Alternative Name: Ozempic

Controls Included


Assay Background

Semaglutide is a GLP-1 analogue with 94% sequence homology to human GLP-1. Semaglutide acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP-1 receptor, the target for native GLP-1. GLP-1 is a physiological hormone that has multiple actions on glucose, mediated by the GLP-1 receptors. The principal mechanism of protraction resulting in the long half-life of semaglutide is albumin binding, which results in decreased renal clearance and protection from metabolic degradation. Furthermore, semaglutide is stabilized against degradation by the DPP-4 enzyme. Semaglutide reduces blood glucose through a mechanism where it stimulates insulin secretion and lowers glucagon secretion, both in a glucose-dependent manner. Thus, when blood glucose is high, insulin secretion is stimulated, and glucagon secretion is inhibited. The mechanism of blood glucose lowering also involves a minor delay in gastric emptying in the early postprandial phase.

Assay Principle

Solid phase enzyme-linked immunosorbent assay (ELISA) based on the sandwich principle. Standards and samples (serum or plasma) are incubated in the microtiter plate coated with the drug semaglutide. After incubation, the wells are washed. Then, Horse Radish Peroxidase (HRP) conjugated probe is added and binds to semaglutide antibodies captured by the drug semaglutide on the surface of the wells. Following incubation wells are washed and the bound enzymatic activity is detected by addition of tetramethylbenzidine (TMB) chromogen substrate. Finally, the reaction is terminated with an acidic stop solution. The color developed is proportional to the amount of semaglutide antibodies in the sample or standard. Results of samples can be determined directly using the standard curve.


Related Products

Anti-Infliximab (Remicade) ELISA Assay Kit
Total Infliximab ELISA Assay
Infliximab ELISA mAb-based Assay

Documents

Product Manual


Please note: All documents above are for reference use only and should not be used in place of the documents included with this physical product. If digital copies are needed, please contact us.

Product Citations